ArticleCancer gene therapy2011

Gene therapy with interleukin-10 receptor and interleukin-12 induces a protective interferon-γ-dependent response against B16F10-Nex2 melanoma.

L H L Marchi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.